Poultry probiotic vaccine compositions and methods of use thereof

Provided herein are compositions including a probiotic including at least one strain of live bacteria and a Marek\u27s Disease vaccine. Compositions including a probiotic or a probiotic and a Marek\u27s Disease vaccine may be administered to subjects, including poultry. The compositions may be administered in ovo to increase early lactic acid bacteria in the gastrointestinal tract of the subject, to decrease the gram negative bacteria in the gastrointestinal tract of the subject, to reduce the level of Salmonella in the gastrointestinal tract of the subject and to increase the body weight gain of the subject. Also provided are kits including a probiotic and a Marek\u27s Disease vaccine

Vaccines as alternatives to antibiotics for food producing animals. Part 2:new approaches and potential solutions

Vaccines and other alternative products are central to the future success of animal agriculture because they can help minimize the need for antibiotics by preventing and controlling infectious diseases in animal populations. To assess scientific advancements related to alternatives to antibiotics and provide actionable strategies to support their development, the United States Department of Agriculture, with support from the World Organisation for Animal Health, organized the second International Symposium on Alternatives to Antibiotics. It focused on six key areas: vaccines; microbial-derived products; non-nutritive phytochemicals; immune-related products; chemicals, enzymes, and innovative drugs; and regulatory pathways to enable the development and licensure of alternatives to antibiotics. This article, the second part in a two-part series, highlights new approaches and potential solutions for the development of vaccines as alternatives to antibiotics in food producing animals; opportunities, challenges and needs for the development of such vaccines are discussed in the first part of this series. As discussed in part 1 of this manuscript, many current vaccines fall short of ideal vaccines in one or more respects. Promising breakthroughs to overcome these limitations include new biotechnology techniques, new oral vaccine approaches, novel adjuvants, new delivery strategies based on bacterial spores, and live recombinant vectors; they also include new vaccination strategies in-ovo, and strategies that simultaneously protect against multiple pathogens. However, translating this research into commercial vaccines that effectively reduce the need for antibiotics will require close collaboration among stakeholders, for instance through public–private partnerships. Targeted research and development investments and concerted efforts by all affected are needed to realize the potential of vaccines to improve animal health, safeguard agricultural productivity, and reduce antibiotic consumption and resulting resistance risks

Application f ionized reactive oxygen species for desinfection of carcasses, table eggs and fertile eggs

Primary Audience: Processing Plant Managers, Hatchery Managers SUMMARY We evaluated the effect of ionized reactive oxygen species created using Binary Ionization Technology (BIT) for disinfection of broiler carcasses, table eggs, and treatment of fertile eggs. Previous research has indicated that BIT creates a high concentration of reactive oxygen species (ROS) that lyse bacterial cells on contact. Application of BIT to broiler carcasses that had been intentionally inoculated with 1.58 × 10 6 Salmonella enterica Enteritidis (SE) caused a 1 to 3 log reduction in recoverable SE, depending on the duration of the treatment. Additionally, after inoculation of table eggs with 6.8 × 10 8 cfu of SE, we recovered SE from 95% fewer eggs following enrichment and found significantly fewer (7.77 and 7.41 log reduction) colony-forming units recovered from eggs treated with BIT compared with nontreated control eggs. We also evaluated whether application of the BIT treatment had any effect on hatchability of broiler breeder eggs to determine whether use of this technology could be feasible in a hatchery environment for disinfection of eggs. There were no significant effects of BIT on the hatchability (of total set) of treated eggs as compared with nontreated control eggs; however, there was a slight numerical increase in hatchability, between 5 and 10% in 2 trials. These data suggest that application of BIT technology to carcasses and table eggs could reduce contamination with pathogens and that the application to fertile eggs may not have effects on hatchability of eggs set

Method for Bacteriophage Delivery and Amplification

Methods of selecting wide host range bacteriophage capable of growing in a plurality of bacteria including pathogenic and non-pathogenic bacteria and bacteriophage selected are described. In addition to methods of treating a subject infected with a pathogenic bacterium using bacteriophage, of decontaminating objects using bacteriophage, of producing vaccines. In another aspect, methods of determining bacterial viability and methods of improving the sensitivity of a biosensor using wide host range bacteriophages are also disclosed

Method for bacteriophage delivery and amplification

Methods of selecting wide host range bacteriophage capable of growing in a plurality of bacteria including pathogenic and non-pathogenic bacteria and bacteriophage selected by the methods are disclosed. Also disclosed are: methods of treating a subject infected with a pathogenic bacterium using bacteriophage, of decontaminating objects using bacteriophage, and of producing vaccines. In another aspect, methods of determining bacterial viability and of improving the sensitivity of a biosensor using wide host range bacteriophages are also disclosed

Genome-Wide Profiling of MicroRNAs in Adipose Mesenchymal Stem Cell Differentiation and Mouse Models of Obesity

In recent years, there has been accumulating evidence that microRNAs are key regulator molecules of gene expression. The cellular processes that are regulated by microRNAs include e.g. cell proliferation, programmed cell death and cell differentiation. Adipocyte differentiation is a highly regulated cellular process for which several important regulating factors have been discovered, but still not all are known to fully understand the underlying mechanisms. In the present study, we analyzed the expression of 597 microRNAs during the differentiation of mouse mesenchymal stem cells into terminally differentiated adipocytes by real-time RT-PCR. In total, 66 miRNAs were differentially expressed in mesenchymal stem cell-derived adipocytes compared to the undifferentiated progenitor cells. To further study the regulation of these 66 miRNAs in white adipose tissue in vivo and their dependence on PPARγ activity, mouse models of genetically or diet induced obesity as well as a mouse line expressing a dominant negative PPARγ mutant were employed